Insulin glargine, a long-acting insulin analog, is essential in managing diabetes, providing steady glucose control over 24 hours. As diabetes cases continue to rise globally, biosimilars of insulin glargine have emerged as affordable alternatives to branded products like Sanofi’s Lantus, reducing the financial burden on healthcare systems and patients alike. Market Outlook for Insulin...

  The CAR-T Treatment Market has gained substantial attention in the field of oncology, offering groundbreaking solutions for treating aggressive and treatment-resistant cancers. Chimeric Antigen Receptor T-cell (CAR-T) therapy modifies a patient's own T-cells to identify and destroy cancer cells effectively. With multiple therapies already approved and ongoing clinical trials showing...

An  Electronic Health Record (EHR) is a digital version of a patient’s medical history,  continuously updated by healthcare professionals. Unlike traditional paper records, EHRs combine clinical, operational, and administrative data into a unified platform that provides quick access to patient details. This digital system is key to advancing healthcare technologies,...